Co-localization of truncated tau and DNA fragmentation in Alzheimerʼs disease neurones
- 1 December 1997
- journal article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 8 (17) , 3709-3712
- https://doi.org/10.1097/00001756-199712010-00010
Abstract
Monoclonal antibody MN423 stains all hallmarks of tau neurofibrillary pathology in Alzheimer's disease (AD), without reacting with full-length tau. It recognizes tau molecules which are cleaved at Glu-391, suggesting that tau is endogenously truncated in AD brains. We investigated whether truncation of tau takes place in pre-tangle neurones. Our results showed that tau truncation occurs inside AD neurones in the absence of other signs of AD neurofibrillary pathology. Using in situ end labelling (ISEL) of DNA we found evidence for DNA fragmentation in a significant subpopulation of MN423-positive neurones. Our results therefore suggest that tau truncation is an early intracellular event preceding cell death in AD.Keywords
This publication has 7 references indexed in Scilit:
- DNA damage and apoptosis in Alzheimer's disease: colocalization with c- Jun immunoreactivity, relationship to brain area, and effect of postmortem delayJournal of Neuroscience, 1996
- Tau as a marker for Alzheimer's diseaseTrends in Biochemical Sciences, 1993
- Tau protein and the neurofibrillary pathology of Alzheimer's diseaseTrends in Neurosciences, 1993
- The Molecular and Cellular Biology of TauBrain Pathology, 1993
- Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament.The EMBO Journal, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991